OPTN
OptiNose Inc

2,048
Loading...
Loading...
News
all
press releases
OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates
Zacks·4mo ago
News Placeholder
More News
News Placeholder
Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Lags Revenue Estimates
Zacks·4mo ago
News Placeholder
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Tops Revenue Estimates
chainwire·4mo ago
News Placeholder
Optinose Shares Soar After Merger Agreement With Paratek Pharmaceuticals: Retail Sentiment Takes Flight
Paratek will acquire Optinose's outstanding shares for $9 apiece in cash, representing a 50% premium to the stock’s closing trading price of $6 on March 19, and up to $5 per share in contingent value rights if XHANCE achieves certain net revenue milestones.
Stocktwits·6mo ago
News Placeholder
Insights Ahead: OptiNose's Quarterly Earnings
read more...
Benzinga·10mo ago
News Placeholder
Optinose to Present at the Needham Virtual Healthcare Conference
YARDLEY, Pa., April 04, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Globe Newswire·1y ago
News Placeholder
Ramy A. Mahmoud Sells 19,198 Shares of OptiNose, Inc. (NASDAQ:OPTN) Stock
OptiNose, Inc. (NASDAQ:OPTN Get Free Report) CEO Ramy A. Mahmoud sold 19,198 shares of the stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price...
Zolmax·1y ago
News Placeholder
Lake Street Capital Boosts OptiNose (NASDAQ:OPTN) Price Target to $4.00
OptiNose (NASDAQ:OPTN Free Report) had its price target raised by Lake Street Capital from $3.00 to $4.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage...
Ticker Report·1y ago
News Placeholder
OptiNose (NASDAQ:OPTN) PT Raised to $4.00
OptiNose (NASDAQ:OPTN Free Report) had its price target raised by Lake Street Capital from $3.00 to $4.00 in a report published on Monday, Benzinga reports. The brokerage currently has a buy...
Zolmax·1y ago
News Placeholder
Optinose price target raised by $1 at Lake Street, here's why
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago

Latest OPTN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.